Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

ZYMEZYME
Showing 6 of 11 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in ZYMEWORKS INC

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 418,497 shares of ZYME (ZYMEWORKS INC), worth $10.9M as of 2026-Q2. The position was decreased (-43.7% shares). ZYME represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$10.9M

Current Shares

418,497

Total Value Change

+$5.8M

Total Shares Change

+10,726

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
418,497
-43.7%
$10.9M0.0%$26.14
0
2026-Q1
Increased
743,898
+6.3%
$18.6M0.0%$24.45
30
2025-Q4
Increased
700,002
+123.1%
$18.4M0.0%$26.54
46
2025-Q3
New
313,753
-
$5.4M0.0%$17.23
37
2024-Q4
Exited
0
-100.0%
$00.0%$14.51
0
2024-Q3
New
407,771
-
$5.1M0.0%$12.42
37

Other major holders of ZYME: BlackRock, Inc., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used